CME Group Inc.
CME
$307.32
-$3.39-1.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.08B | 5.96B | 6.01B | 5.85B | 5.70B |
| Total Other Revenue | 422.60M | 423.00M | 425.60M | 428.20M | 421.90M |
| Total Revenue | 6.51B | 6.39B | 6.43B | 6.27B | 6.12B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.51B | 6.39B | 6.43B | 6.27B | 6.12B |
| SG&A Expenses | 1.75B | 1.69B | 1.68B | 1.65B | 1.65B |
| Depreciation & Amortization | 330.90M | 331.90M | 333.20M | 334.00M | 336.80M |
| Other Operating Expenses | 166.10M | 196.50M | 204.30M | 201.20M | 200.80M |
| Total Operating Expenses | 2.25B | 2.22B | 2.22B | 2.19B | 2.18B |
| Operating Income | 4.26B | 4.16B | 4.21B | 4.09B | 3.94B |
| Income Before Tax | 5.33B | 4.85B | 4.85B | 4.67B | 4.54B |
| Income Tax Expenses | 1.26B | 1.08B | 1.08B | 1.05B | 1.02B |
| Earnings from Continuing Operations | 4.07K | 3.76K | 3.77K | 3.63K | 3.53K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.07B | 3.76B | 3.77B | 3.63B | 3.53B |
| EBIT | 4.26B | 4.16B | 4.21B | 4.09B | 3.94B |
| EBITDA | 4.59B | 4.49B | 4.55B | 4.42B | 4.27B |
| EPS Basic | 11.18 | 10.33 | 10.35 | 9.96 | 9.69 |
| Normalized Basic EPS | 9.23 | 8.41 | 8.41 | 8.11 | 7.88 |
| EPS Diluted | 11.16 | 10.32 | 10.33 | 9.94 | 9.67 |
| Normalized Diluted EPS | 9.22 | 8.40 | 8.40 | 8.10 | 7.87 |
| Average Basic Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Average Diluted Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Dividend Per Share | 5.00 | 4.90 | 4.80 | 4.70 | 4.60 |
| Payout Ratio | 96.58% | 103.53% | 102.42% | 105.42% | 101.66% |